FBT

First Trust NYSE Arca Biotechnology Index Fund [FBT] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

FBT Stock Summary

Top FBT Correlated Resources

FBT


Top 10 Correlated ETFs

FBT


Top 10 Correlated Stocks

FBT


In the News

07:31 11 Dec 2023 FBT

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

A smart beta exchange traded fund, the First Trust NYSE Arca Biotechnology ETF (FBT) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market.

07:31 11 Dec 2023 FBT

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.

07:31 11 Dec 2023 FBT

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Launched on 06/19/2006, the First Trust NYSE Arca Biotechnology ETF (FBT) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market.

07:31 11 Dec 2023 FBT

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund launched on 06/19/2006.

07:55 11 Dec 2023 FBT

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund launched on 06/19/2006.

07:50 11 Dec 2023 FBT

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

The First Trust NYSE Arca Biotechnology ETF (FBT) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.

03:00 11 Dec 2023 FBT

Here are the top-performing ETFs in first half of 2023 as crypto-related funds soar

Hello! This week's ETF Wrap looks at top performers in the first half of 2023, as well as flows, as stocks rally and crypto-related funds jump so far this year.

05:18 11 Dec 2023 FBT

FBT: No Great Prospects Despite Huge Price Gain Over Past One Year

Most stocks in FBT's biotechnology portfolio beat returns of S&P 500 during the past one year. FBT also registered a price growth of 15.5 percent. However, over the past five months, return has been much lower than S&P 500, and price growth of FBT's portfolio has largely been disappointing. There is a likelihood of this price falling further down to cross the 52-week low. This assumption gets further validation through moving average indicators.

07:34 11 Dec 2023 FBT

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Launched on 06/19/2006, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.

07:39 11 Dec 2023 FBT

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

The First Trust NYSE Arca Biotechnology ETF (FBT) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.

FBT Financial details

Company Rating
-
Market Cap
3.01B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
4.33%
SMA50
-2.69%
SMA100
-7.69%
Inst Own
21.68%
Inst Trans
0.98%
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
20.85M
Shs Float
0
-
-
-
-
Target Price
-
52W Range
130.27-166.0
52W High
-13.04%
52W Low
+11.05%
RSI
59.21
Rel Volume
0.55
Avg Volume
31.23K
Volume
17.12K
Perf Week
2.75%
Perf Month
6.1%
Perf Quarter
-9.26%
Perf Half Y
-8.09%
-
-
-
-
Beta
0.69
-
-
Volatility
1.27%, 3.61%
Prev Close
-0.93%
Price
144.36
Change
-0.3%

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap